Sharon Barrans
St James's University Hospital(GB)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research, Viral-associated cancers and disorders, Immune Cell Function and Interaction
Most-Cited Works
- → Rearrangement of MYC Is Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab(2010)549 cited
- → Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report(2020)484 cited
- → Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy(2018)294 cited
- → Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma(2002)280 cited
- → Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial(2019)261 cited
- → Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium(2019)247 cited
- → Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome(2004)219 cited
- → A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial)(2008)214 cited
- → Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma(2015)206 cited
- → Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression(2015)171 cited